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Abstract
The biocatalytic preparation of trans-hex-2-enal from trans-hex-2-enol using a novel aryl alcohol oxidase from Pleurotus eryngii
(PeAAOx) is reported. As O2-dependent enzyme PeAAOx-dependent reactions are generally plagued by the poor solubility of O2
in aqueous media and mass transfer limitations resulting in poor reaction rates. These limitations were efficiently overcome by con-
ducting the reaction in a flow-reactor setup reaching unpreceded catalytic activities for the enzyme in terms of turnover frequency
(up to 38 s−1) and turnover numbers (more than 300000) pointing towards preparative usefulness of the proposed reaction scheme.
Introduction
trans-2-Hexenal is well-known as a major component of the
Green Notes of fruits and vegetables such as apples, straw-
berries, cherries and more. It is widely used in the flavour and
fragrance industry as fresh flavour ingredient in foods and
beverages.
One attractive access to trans-2-hex-2-enal is the oxidation of
the corresponding allylic alcohol to the aldehyde. Though at
first sight an oxidation of primary alcohols to the correspond-
ing aldehydes does not appear to be a major challenge, the
methods of the state-of-the-art are mostly plagued by undesired
side reactions [1]. Also some of the stoichiometric oxidants
used are questionable from an environmental and/or toxicolog-
ical point of view and therefore are not compatible with con-
sumer products such as Green Notes. Therefore, we turned our
attention to biocatalytic oxidation methods. For clean conver-
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sion of primary alcohols to aldehydes principally two biocat-
alytic approaches are available (Scheme 1) [2-5]. Alcohol dehy-
drogenases catalyse the reversible oxidation of alcohols in a
Meerwein–Ponndorf–Verley-type of reaction (Scheme 1A). The
poor thermodynamic driving force of this reaction, however,
necessitates significant molar surpluses of the stoichiometric
oxidant (such as acetone). This not only negatively influences
the environmental impact of the reaction [6] but also compli-
cates downstream processing. Furthermore, the nicotinamide
cofactor (even if used in catalytic amounts only) causes addi-
tional costs.
Scheme 1: Enzymatic reaction schemes for the selective oxidation of
trans-hex-2-enol. A: Alcohol dehydrogenase (ADH)-catalysed oxida-
tion producing stoichiometric amounts of NAD(P)H, which needs to be
recycled in situ; the overall reaction is reversible requiring surpluses of
the cosubstrate (e.g., acetone) to shift the overall equilibrium to the
side of trans-hex-2-enal. B: Envisioned aerobic oxidation using alcohol
oxidases (AOx). H2O2 is formed as byproduct and dismutated by cata-
lase into H2O and O2.
Therefore, we concentrated on alcohol oxidase-catalysed reac-
tion schemes (Scheme 1B. Oxidases utilise O2 as terminal elec-
tron acceptor for the oxidation reaction yielding H2O2 as sole
byproduct. The latter can be disproportionated easily by using
catalase (Scheme 1B). Furthermore, O2 reduction adds suffi-
cient thermodynamic driving force to the reaction to make it
essentially irreversible.
The benefits of using O2, however, also come with the disad-
vantage of its very poor solubility in aqueous media (ca.
0.25 mM at room temperature). Hence, in the course of an oxi-
dation reaction dissolved O2 is consumed rapidly and diffusion
of O2 into the reaction medium can easily become overall rate-
limiting. The O2 diffusion rate into the reaction medium directly
correlates with the interfacial area between aqueous medium
and the gas phase. Large interfacial surface areas can be
achieved via heterogeneous intake, by bubbling, stirring, etc.
Soluble enzymes, however, are often rather unstable under these
conditions, possibly owing to the mechanical stress leading to
irreversible inactivation of the biocatalyst [7,8]. Methods of
bubble-free aeration have been described in the literature to
alleviate the inactivation issue described above [9-12].
The continuous-flow microreactor technology has emerged as a
safe and scalable way to approach oxidation reactions [13,14].
Due to its small dimensions, hazardous reactions can be easily
controlled, owing to the large surface-to-volume ratio which
can minimise hot-spot formation and allows for control over
mixing and heating phenomena [15,16]. Furthermore, a well-
defined gas–liquid regime can be easily maintained [17,18].
High mass-transfer coefficients are generally the consequence
of small vortices induced by the segmented flow regime. This
flow pattern guarantees an enhanced contact between the two
phases and provides a uniform gas concentration in the liquid
segment.
Therefore, it is not very astonishing that also the biocatalysis
community is showing interest in flow chemistry. Several
biocatalytic processes have been reported in flow reactors [19],
mostly advocating easier process intensification in combination
with enzyme immobilization [20-23]. Also the higher oxygen-
transfer rates in flow reactions compared to batch reactions
have been emphasised by several groups. Here, reactor designs
ranging from simple flow reactors, tube-in-tube reactors [24],
agitated tube reactors [25,26] and continuous agitated cell reac-
tors [27] have been reported.
Encouraged by these contributions, we asked ourselves whether
a slug-flow approach may combine mechanically less
demanding conditions with high O2-transfer rates thereby
enabling efficient and robust oxidase-catalysed oxidation reac-
tions.
Results and Discussion
Selection and characterisation of the
biocatalyst
As biocatalyst for this study we focussed on the recombinant
aryl alcohol oxidase from Pleurotus eryngii (PeAAOx) [28-31].
Especially the availability as recombinant enzyme (enabling
future at-scale production and protein engineering) and its
promising activity on allylic alcohols make PeAAOx a promis-
ing starting point. Commercially available alcohol oxidases
from Pichia pastoris and Candida boidinii showed no signifi-
cant activity for the substrate under the same conditions. As
trans-2-hex-enol had not been reported as substrate for
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residence time [min] [product]
[mM]
1:1 0.20 0.20 15 5.48 (± 0.01)
1:3 0.10 0.30 15 5.18 (± 0.32)
1:5 0.067 0.333 16 4.99 (± 0.49)
Conditions: 3 mL flow reactor, 50 mM KPi buffer (pH 7, 30 °C), [trans-2-hexen-1-ol]0 = 10 mM, [PeAAOx] = 0.25 µM, [catalase] = 600 U mL−1.
PeAAOx we evaluated its catalytic properties, particularly the
substrate concentration-dependency of the enzymatic oxidation.
Initial rate measurements (performed in 1 mL cuvettes) revealed
a Michaelis–Menten dependency of the enzyme activity
(Figure 1). Apparent KM and kcat values of approximately 1 mM
and 22 s−1 were estimated, respectively. These values are in the
same order of magnitude as those for benzyl alcohol substrates
reported previously [29]. The slightly decreasing enzyme activi-
ty at elevated substrate concentrations may be an indication for
a slight substrate inhibition. Performing these initial rate mea-
surements in the presence of varying product concentrations
showed a pronounced product inhibition (Supporting Informa-
tion File 1, Figure S2, vide infra).
Figure 1: Michaelis–Menten kinetics of the PeAAOx-catalysed oxida-
tion of trans-hex-2-enol. Conditions: 50 mM KPi buffer (pH 7, 30 °C),
[trans-hex-2-enol]0 = 3 mM, [PeAAOx] = 0.044 µM, [horseradish perox-
idase] = 500 U mL−1, [ABTS] = 2 mM.
Continuous-flow reactor enzymatic oxidation
Next, we performed the PeAAOx-catalysed oxidation of trans-
hex-2-enol in a slug-flow reactor setup (Supporting Informa-
tion File 1, Figure S1 and Figures S9–S11). In a first set of ex-
periments we systematically varied the residence time of the
reaction mixture in the flow reactor (and thereby the reaction
time, Figure 2).
Figure 2: The influence of the residence time on the conversion of
trans-hex-2-enol (red squares) to trans-2-hexenal (black diamonds) in
a flow reactor. Conditions: 3 mL flow reactor, 50 mM KPi buffer (pH 7,
30 °C), [trans-hex-2-enol]0 = 10 mM, [PeAAOx] = 0.25 µM, [catalase] =
600 U mL−1.
A full conversion of the starting material into the desired trans-
hex-2-enal was observed at residence (reaction) times of
approximately 40 min corresponding to a turnover number (TN)
for the biocatalysts of 32400 and an average turnover frequen-
cy (TF) of 13.5 s−1. Even more interestingly, at higher flow
rates apparent TF of up to 38 s−1 (RT = 5 min) were observed.
This value exceeds the previously determined kcat(PeAAOx)
(Figure 1) significantly. We attribute this observation to an in-
creased oxygen-transfer rate at high flow rates. In the case of
the 5 minutes residence time this corresponds to an O2-transfer
rate of roughly 0.25 mM min−1. Similarly high values could be
obtained previously only under mechanically demanding reac-
tion conditions or using surfactant-stabilised emulsions [7].
Varying the ratio of gas to liquid had no significant effect on the
overall rate of the reaction (Table 1).
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Within the experimental error, the conversion in all experi-
ments was identical indicating that even at a comparably low
volumetric ratio of 1:1 the O2 availability was already suffi-
cient not to be overall rate-limiting.
It is worth mentioning here that under batch reaction conditions,
similar progression curves were only attainable under mechani-
cally very demanding conditions (i.e., very vigorous stirring and
bubbling of O2 directly into the reaction mixture, Supporting
Information File 1, Figure S3). These conditions also caused a
significant evaporation of the substrate at higher substrate con-
centration (Supporting Information File 1, Figure S4), which
was much less the case in the flow-reaction setup.
From an economical point-of-view the catalyst performance in
terms of turnover number (TN) is of utmost importance as it
directly correlates with the cost-contribution of the catalyst to
the production costs [32-34]. Therefore we evaluated the TN
attainable for PeAAOx in the flow setup (Figure 3). For this
lower PeAAOx concentrations as well as significantly in-
creased residence times were applied. The increased residence
times were achieved by decreasing the flow rates and using a
longer flow reactor (6 mL volume instead of 3 mL).
Figure 3: Increasing the PeAAOx turnover numbers (TN) by increas-
ing the residence time. Conditions: 6 mL flow reactor, 50 mM KPi
buffer (pH 7, 30 °C), [trans-hex-2-enol]0 = 40 mM, [PeAAOx] = 0.02
µM, [catalase] = 600 U mL−1. The TN value was calculated based on
the GC yield of every run. The TN was obtained by dividing the prod-
uct concentration (as determined chromatographically) by the biocata-
lyst concentration.
Pleasingly, already in these first experiments a TN for the en-
zyme of more than 300000 was observed at long residence
times. This also underlines the robustness of the enzyme under
the flow conditions. Compared to Figure 2 somewhat lower TFs
for PeAAOx were observed here, which again can be attributed
to a lower O2-transfer rate at lower flow rates. The quasi-linear
relationship shown in Figure 3 also suggests that even higher
TN may be attainable – however at the expense of longer reac-
tion times. Therefore, further investigations will focus on identi-
fying conditions satisfying the demand for high TNs and short
reaction times. Encouraged by these results, we also tried a
semi-preparative scale reaction using 5 g L−1 (50 mM) sub-
strate loading in a total of 50 mL with 0.75 μM PeAAOx. As a
result, 90% conversion was achieved after 18 h of total reaction
time (roughly 80 minutes of residence time in the 6 mL reactor).
The product was purified chromatographically resulting in 200
mg of pure trans-hex-2-enal (as determined by NMR) in 81%
isolated yield thereby demonstrating the preparative potential of
the proposed reaction setup.
Conclusion
Alcohol oxidase-catalysed oxidation of alcohols to aldehydes
bears a significant potential for preparative biocatalysis. The
reaction is independent from expensive and instable nicotin-
amide cofactors (and the corresponding cosubstrates/coprod-
ucts as well as possible regeneration enzymes) and produces
only water as byproduct. These advantages, however, are coun-
teracted by the generally low reaction rates caused by the poor
O2 availability. Flow chemistry is a promising technique to
provide the aqueous reaction mixture with O2 needed for the
oxidation. It enables high O2 transfer rates while avoiding en-
zyme robustness issues frequently observed with ‘traditional’
aeration methods.
Future developments in our laboratories will concentrate on the
characterisation, extension and preparative demonstration of
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For the production, activation and purification of PeAAOx, a
slightly modified literature protocol was used [28]. Pre-cultures
of LB media containing 100 μg mL−1 of ampicillin were
inoculated with E. coli W3110 containing pFLAG1-AAO and
incubated overnight at 37 °C and 180 rpm. Overexpression
was carried out in 5 L flasks with 1 L of TB medium supple-
mented with 100 μg mL−1 of ampicillin. The medium was
inoculated with the pre-culture to an OD of 0.05 and grown
at 37 °C and 180 rpm. At an OD600 of 0.8, 1 mM isopropyl
β-D-thiogalactopyranoside (IPTG) was added and the cultures
were incubated for additional 4 h at 37 °C and 180 rpm. The
bacterial pellets, obtained after harvesting the cells, were
re-suspended in a total volume of 40 mL 50 mM Tris/HCl
buffer, pH 8.0, containing 10 mM EDTA and 5 mM dithio-
threitol (DTT).
Refolding
The re-suspended cells were disrupted by incubation with
2 mg mL−1 lysozyme for 1 h at 4 °C. Afterwards, 0.1 mg mL−1
DNase, 1 mM MgCl2 and 0.1 mM PMSF were added followed
by sonication. The insoluble fraction was collected by centrifu-
gation (30 min at 15,000 rpm and 4 °C), re-suspended and
washed three times with 20 mL 20 mM Tris/HCl buffer, pH 8.0,
containing 10 mM EDTA and 5 mM DTT using a potter
homogenizing device. The pellets obtained after centrifugation
(15 min at 15,000 rpm and 4 °C) were solubilized in a total
volume of 30 mL 20 mM Tris/HCl buffer, pH 8.0, containing
2 mM EDTA, 50 mM DTT and 8 M urea. After incubation on
ice for 30 min, the solution was cleared by centrifugation
(15 min at 15,000 rpm and 4 °C). The obtained supernatant was
used as stock solution for the in vitro refolding.
The PeAAOx was solubilized using 150 µg mL−1 protein in
20 mM Tris/HCl buffer, pH 9.0, containing 2.5 mM GSSG,
1 mM DTT, 0.02 mM FAD, 34% glycerol and 0.6 M urea at
4 °C for 80 h. After the incubation for PeAAOx activation/
refolding, the refolding mixture was concentrated to 100 mL
and the buffer exchanged against 10 mM sodium phosphate
buffer, pH 5.5 by diafiltration (DV 20) and subsequently
concentrated using an Amicon Ultra 15 mL centrifugal filter
(MWCO 10 kDa). After centrifugation (overnight at 15,000 rpm
and 4 °C), the soluble fraction was further purified using anion-
exchange chromatography.
Purification
The concentrated PeAAOx solution was purified using a 58 mL
Q Sepharose column (GE Healthcare). PeAAOx was eluted
with a linear NaCl gradient (0–0.6 M over 6 CV) using 10 mM
sodium phosphate buffer, pH 5.5. Fractions containing
PeAAOx were pooled, concentrated and desalted using HiTrap
desalting columns (GE Healthcare) and 10 mM sodium phos-
phate buffer, pH 5.5. The PeAAOx concentration was calcu-
lated based on the absorbance using the molar extinction coeffi-
cient of ε463 11,050 M−1 cm−1.
Activity assay
The activity of PeAAOx was determined by UV–vis spectros-
copy, using an Agilent Cary 60 UV–vis spectrophotometer,
following the oxidation of ABTS (ε405 = 36,800 M−1 cm−1) by
horseradish peroxidase (POD) at the expense of hydrogen
peroxide. In general, 0.044 µM PeAAOx was used to convert
3 mM of trans-2-hex-2-enol. The hydrogen peroxide formed in
this reaction was subsequently used to convert 2 mM of ABTS
to ABTS·+ by an excess of POD (500 U mL−1). The reactions
were performed at 30 °C in oxygen-saturated 50 mM KPi buffer
at pH 7.0.
Flow reactor experiments
PFA microreactor coils (750 μm ID) with a volume of 3 and
6 mL were constructed. The reaction mixture was introduced
via a syringe pump (Fusion 200, Chemyx), while the pure
oxygen flow was controlled by a mass flow controller (EL-
FLOW, Bronkhorst), resulting in a segmented flow (Supporting
Information File 1, Figure S8). Residence times were taken as
the time between the solution entering and exiting the coil and
were varied by altering the flow, keeping the ratio of oxygen to
liquid at three to one. Samples were collected on ice and as
soon as enough volume was collected, extracted with ethyl
acetate and analysed by GC (vide infra).
GC analysis
The collected reaction mixtures were extracted into an equal
volume of ethyl acetate, dried with magnesium sulphate and
analysed on a CP-wax 52 CB GC column (50 m × 0.53 m ×
2 µm) (GC method: 60 °C for 3 min; 30 °C/min to 105 °C;
105 °C for 7 min; 30 °C/min to 250 °C; 250 °C for 1 minute).
Dodecane (5 mM) was added as standard.
Work-up semi-preparative scale
The reaction mixture was directly collected in deuterated
chloroform at the end of the flow reactor followed by recording
the NMR spectrum in order to evaluate the conversion (see Sup-
porting Information File 1). The organic mixture was diluted
and introduced into a separation funnel and washed with brine.
The aqueous phase was backwashed once with DCM. The
collected organic phase was dried over MgSO4, filtered and
concentrated under reduced pressure. Purification of the isolat-
ed mixture was performed by flash chromatography on silica
(pure DCM). The final product was obtained as colourless oil
(200 mg).
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(E)-Hex-2-enal
TLC (DCM) Rf 0.9; 1H NMR (399 MHz, CDCl3) δ 9.44 (d, J =
7.7 Hz, 1H), 6.78 (dt, J = 15.6, 6.8 Hz, 1H), 6.05 (ddq, J = 15.5,
7.8, 1.3 Hz, 1H), 2.33–2.18 (m, 2H), 1.48 (h, J = 7.4 Hz, 2H),
0.90 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 194.3,
158.9, 133.3, 34.8, 21.3, 13.8.
Supporting Information
Supporting Information File 1
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